Harnessing the Tumor Suppressor Function of FOXO as an Alternative Therapeutic Approach in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|9|1311-1321

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.9, 2011-08, pp. : 1311-1321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targets in the ARF Tumor Suppressor Pathway

By  

Current Medicinal Chemistry, Vol. 14, Iss. 17, 2007-07 ,pp. : 1815-1827

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 460-471

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tumor Suppressor Networks for Cancer Therapeutics

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 2-16

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer

By Otani Koji   Li Xiaoxing   Arakawa Tetsuo   Chan Francis KL   Yu Jun  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 5, 2013-06 ,pp. : 445-455

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite